menu
    • menu

    Company profile for Nuvig Therapeutics

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Willow Birch Pharma delivers trusted, high-quality APIs nationwide with unmatched service, compliance, and competitive value.

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Nuvig Therapeutics is advancing innovative and transformational therapies that are designed to induce natural mechanisms to restore immune homeostasis, rebalance immune function following inflammation, and improve the treatment options for patients. Nuvig is building a pipeline of novel immune therapeutics for chronic inflammatory and autoimmune diseases. The company relies on the therapeutic induction of natural mechanisms o...
    Nuvig Therapeutics is advancing innovative and transformational therapies that are designed to induce natural mechanisms to restore immune homeostasis, rebalance immune function following inflammation, and improve the treatment options for patients. Nuvig is building a pipeline of novel immune therapeutics for chronic inflammatory and autoimmune diseases. The company relies on the therapeutic induction of natural mechanisms of immune homeostasis to modulate immune function, enabling doctors with improved treatment options for patients with chronic inflammatory and autoimmune diseases.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Nuvig TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    1775 Woodside Road Suite 201 Redwood City, CA 94061
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.nuvigtherapeutics.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/nuvig-therapeutics-inc/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Nuvig Therapeutics Names Celia J.F. Lin MD Chief Medical Officer
    Nuvig Therapeutics Names Celia J.F. Lin MD Chief Medical Officer

    18 Nov 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251113419323/en/Nuvig-Therapeutics-Appoints-Celia-J.F.-Lin-M.D.-as-Chief-Medical-Officer

    BUSINESSWIRE
    18 Nov 2025
    Share Share
    Nuvig Therapeutics Names David CEO, James Mackay Board Chair
    Nuvig Therapeutics Names David CEO, James Mackay Board Chair

    09 Sep 2025

    // PHARMAWEB

    https://www.pharmiweb.com/press-release/2025-09-09/nuvig-therapeutics-appoints-david-j-woodhouse-phd-as-chief-executive-officer-and-james-mackay

    PHARMAWEB
    09 Sep 2025
    Share Share
    Nuvig Therapeutics: First Patient Dosed in Phase 2 CIDP Trial
    Nuvig Therapeutics: First Patient Dosed in Phase 2 CIDP Trial

    14 May 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250514542461/en/Nuvig-Therapeutics-Announces-First-Patient-Dosed-in-Phase-2-CIDP-Trial-of-NVG-2089-and-Presentation-of-Phase-1-Data

    BUSINESSWIRE
    14 May 2025
    Share Share
    Nuvig Therapeutics Announces $161M Series B and Ph 2 Progress
    Nuvig Therapeutics Announces $161M Series B and Ph 2 Progress

    05 Dec 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20241205877164/en

    BUSINESSWIRE
    05 Dec 2024
    Share Share
    Nuvig Initiates Development of Next-Generation Immune Modulator NVG-2089
    Nuvig Initiates Development of Next-Generation Immune Modulator NVG-2089

    12 Feb 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240212570962/en

    BUSINESSWIRE
    12 Feb 2024
    Share Share
    Nuvig Therapeutics Appoints Dr. Alan Glicklich Chief Medical Officer
    Nuvig Therapeutics Appoints Dr. Alan Glicklich Chief Medical Officer

    04 Oct 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20231004445393/en

    BUSINESSWIRE
    04 Oct 2023
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search